DAFNA Capital Management LLC
Q2 2025 13F Holdings
- Locationlos angeles, CA
- Num holdings
76
- Value ($000)
$362,250
- Date Filed08/14/2025
- Form type13F-HR
- CIK0001389933
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
KRE SPDR S&P BIOTECH ETF | ETF | 78464A870 | $34.46M | 10 % | 415,505 | ||
RJR1 STEREOTAXIS INC | COM NEW | 85916J409 | $29.00M | 8 % | 13,680,554 | ||
RVMD REVOLUTION MEDICINES INC | COM | 76155X100 | $24.91M | 7 % | 677,176 | ||
BPMC BLUEPRINT MEDICINES CORP | COM | 09627Y109 | $21.63M | 6 % | 168,763 | ||
MERUS BV | COM | N5749R100 | $20.98M | 6 % | 398,804 | ||
ATRC ATRICURE INC | COM | 04963C209 | $19.41M | 5 % | 592,273 | ||
CYTK CYTOKINETICS INC | COM NEW | 23282W605 | $13.15M | 4 % | 398,100 | ||
IDYA IDEAYA BIOSCIENCES INC | COM | 45166A102 | $13.01M | 4 % | 619,090 | ||
IBB ISHARES NASDAQ BIOTECH INDX | ETF | 464287556 | $12.97M | 4 % | 102,500 | ||
ASND ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | $12.54M | 4 % | 72,677 |
Rows Per Page
10
- 10
- 50
- 100